BioNTech SE/$BNTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
Ticker
$BNTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
6,772
ISIN
US09075V1026
Website
BioNTech SE Metrics
BasicAdvanced
$24B
-
-$3.62
1.36
-
Price and volume
Market cap
$24B
Beta
1.36
52-week high
$129.27
52-week low
$76.53
Average daily volume
1.3M
Financial strength
Current ratio
10.183
Quick ratio
9.864
Long term debt to equity
1.255
Total debt to equity
1.548
Interest coverage (TTM)
-80.81%
Management effectiveness
Return on assets (TTM)
-3.67%
Return on equity (TTM)
-3.94%
Valuation
Price to revenue (TTM)
7.6
Price to book
1.25
Price to tangible book (TTM)
1.39
Price to free cash flow (TTM)
-17.551
Growth
Revenue change (TTM)
0.61%
Earnings per share change (TTM)
-786.52%
3-year revenue growth (CAGR)
-50.97%
3-year earnings per share growth (CAGR)
-59.88%
What the Analysts think about BioNTech SE
Analyst ratings (Buy, Hold, Sell) for BioNTech SE stock.
BioNTech SE Financial Performance
Revenues and expenses
BioNTech SE Earnings Performance
Company profitability
BioNTech SE News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BioNTech SE stock?
BioNTech SE (BNTX) has a market cap of $24B as of May 27, 2025.
What is the P/E ratio for BioNTech SE stock?
The price to earnings (P/E) ratio for BioNTech SE (BNTX) stock is 0 as of May 27, 2025.
Does BioNTech SE stock pay dividends?
No, BioNTech SE (BNTX) stock does not pay dividends to its shareholders as of May 27, 2025.
When is the next BioNTech SE dividend payment date?
BioNTech SE (BNTX) stock does not pay dividends to its shareholders.
What is the beta indicator for BioNTech SE?
BioNTech SE (BNTX) has a beta rating of 1.36. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.